Premature Ventricular Complexes: Diagnose, Evaluation, and Management
Abstract
Keywords
Full Text:
PDFReferences
Wexler R K, Pleister A, Raman, SV. Palpitations: Evaluation in The Clinical Setting. Am Fam Physician. 2017:(96)784-9.
Temiz A, Gazi E, Altun B, Gungor O, Barutcu A, Bekler A, et al. Fragmented QRS is associated with frequency of premature ventricular contraction in patients without overt cardiac diseases. Anatolian J Cardiol. 2015;(15) :456-62.
Rolando AH, Felani MR Frequent Ventricular Extrasystoles. Cermin Dunia Kedokteran. 2018;(45):759-762.
Perez-SIlva A, Merino JL. Frequent ventricular extrasystoles: significance, prognosis and treatment. E-journal of Cardiology Practice. 2011(9)
Premature Ventricular Contractions. https://my.clevelandclinic.org. Cleveland Clinic. [Online] [Cited: 11 17, 2021.] https://my.clevelandclinic.org/health/diseases/17381-premature-ventricular-contractions.
Conditions & Treatments: premature-ventricular-contractions-pvcs-and-premature. Frankel Cardiovascular Center University of Michigan. www.umcvc.org. [Online] [Cited: 11 17, 2021.] https://www.umcvc.org/conditions-treatments/premature-ventricular-contractions-pvcs-and-premature.
J, CLine. Implantable loop recorders vs. Holter monitors. Wolters Kluwer Health. 2017:(47)
Andarade JG, Bennett MT, Deyell MW, Hawkins N, Krahn AD, Macle L, et al. The Clinical Cardiac Electrophysiology Handbook. Minneapolis : Cardiotext Publishing, LLC, 2016. pp. 229-262.
Burns E dan Buttner R. Premature Ventricular Complex (PVC) . Life In The Fastlane. https://litfl.com. [Online] 6 2, 2021. [Cited: 11 17, 2021.] https://litfl.com/premature-ventricular-complex-pvc-ecg-library/.
GM, Marcus. Evaluation and Management of Premature Ventricular Complexes. 2020;(141)1404-1418.
W, Shimizu. Arrhythmias originating from the right ventricular outflow tract: how to distinguish malignant from benign? Heart Rhythm. 2009(6)1507-11.
Baman TS, Lange DC, Ilg KJ, Gupta SK, Liu TY, Alguire C, et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm. 2010;7(1): 865-9.
Hasdemir C, Ulucan C, Yavuzgil O, Yuksel A, Kartal Y, Simsek E, et al. Tachycardia induced cardiomyopathy in patients with idiopathic ventricular arrhythmias the incidence, clinical and electrophysiologic characteristics, and the predictors. J Cardiovasc Electrophysiol. 2011. 22(1):663668.
Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Circulation. 2017;138:272391.
Kubac G, Klinke WP, Grace M. Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature. Heart Rhythm. 2012;9:1465-72.
Zhong L, Lee YH, Huang XM, Asirvatham SJ, Shen WK, Friedman PA. Relative efficacy of catheterablation vs antiarrhythmic drugs in treating premature ventricular contractions a single-center retrospective study., et al. Heart Rhythm. 2014;(11):187-193.
Stec S, Sikorska A, Zaborska B, Kry?ski T, Szymot J, Ku?akowski P. Benign symptomatic premature ventricular complexes: short- and long-term efficacy of antiarrhythmic drugs and radiofrequency ablation. Kardiol Pol, 2012;(70):351358.
Morganroth J, Goin JE. Quinidine-related mortality in the short-tomedium-term treatment of ventricular arrhythmias. Circulation. 1991;84:197783.
Waldo AL, Camm AJ, deRuyter H. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Lancet. 1996;348:7-12.
Arnar DO, Mairesse GH, Boriani G, Calkins H, Chin A, et al. Management of asymptomatic arrhythmias: a European Heart RhythmAssociation (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm. Europace. 2019;10: 1-32.
DOI: https://doi.org/10.30596/bf.v7i1.9684
DOI (PDF): https://doi.org/10.30596/bf.v7i1.9684.g6854
Refbacks
- There are currently no refbacks.
JURNAL BULETIN FARMATERA
Gedung Kampus 1 Universitas Muhammadiyah Sumatera Utara (UMSU) Lantai II, Laboratorium Farmakologi dan Terapi Fakultas Kedokteran UMSU Jalan Gedung Arca No. 53 Medan Sumatera Utara Indonesia, Kode Pos 20217.
Contact (WA): 0812-6208-2844
E-mail: farmatera@umsu.ac.id
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.